How do peptides work?
How do peptides work? These mechanism articles are the how behind the what. If you want to understand what a GLP-1 dual agonist actually does after injection, why a growth hormone peptide works with your pituitary instead of around it, or which receptor a molecule binds — this is that shelf.
Written to be understood like you're fifteen, sourced from the primary literature, and honest wherever the mechanism is still a hypothesis rather than settled science.
148 articles on this topic
-
Semaglutide for Fatty Liver: What Evidence Shows
Semaglutide has strong biopsy-based evidence in adults with MASH and F2–F3 fibrosis. That is narrower than “fatty liver,” and it does not make every semaglutide formulation interchangeable.
-
Tirzepatide Pyridoxine: What Vitamin B6 Adds
Tirzepatide/pyridoxine is a compounded combination of tirzepatide and vitamin B6. The B6 is usually included with nausea in mind, but no clinical trial has shown that the combination works better than tirzepatide alone.
-
What Are Peptides? A Plain-English Guide
Peptides are short chains of amino acids that the body uses as signals. The same broad family includes natural hormones, established medicines and experimental compounds, so the name alone says little about evidence or safety.
-
How Long Does BPC-157 Take to Work?
No human trial establishes a reliable BPC-157 onset. Animal studies measured changes from day 1 through several weeks, but a prescribed course is judged by the specific outcome and follow-up—not a promised start day.
-
Peptides vs Steroids: What Makes Them Different?
Peptides and anabolic steroids are different molecules with different targets, evidence, risks, and legal status. A peptide is not simply a steroid under a newer name.
-
PT-141 for Men: What the Male Studies Show
PT-141 produced measurable erectile responses in early male trials, including studies involving men who reported an inadequate response to sildenafil. The evidence is limited, route-specific, and not the same as an established male indication.
-
Semaglutide Drug Interactions: What Matters
Most semaglutide interactions are not classic liver-enzyme conflicts. The practical concerns are low blood sugar with insulin or sulfonylureas and altered absorption of oral medicines that need tightly controlled exposure.
-
Tesamorelin for Belly Fat: What the Studies Show
Tesamorelin has reduced visceral abdominal fat in randomized trials, most convincingly in adults with HIV-associated lipodystrophy. That evidence does not make it a general weight-loss drug or a reliable way to shrink the fat just under the skin.
-
Tirzepatide Plateau: Why Weight Loss Slows
A tirzepatide plateau is usually the point where a smaller body and stronger biological pressure to maintain weight balance the medication's effects. A brief stall is not the same thing, and a prescriber should review the pattern before changing treatment.
-
BPC-157 for Inflammation: What the Evidence Shows
Rodent studies report smaller gut lesions, lower oxidative-stress measures and altered inflammatory signaling. No human trial has shown that BPC-157 lowers inflammation.
-
Peptides for Joint Pain: What the Evidence Shows
Peptides for joint pain are being studied, but the evidence is mostly cell and animal work. One uncontrolled 16-person knee follow-up is not enough to show that BPC-157, TB-500 or their combination repairs human joints.
-
Tesamorelin vs Ipamorelin: What Sets Them Apart
Both peptides signal the pituitary to release growth hormone, but they use different receptors and carry very different levels of human evidence. Tesamorelin has phase 3 trial data; ipamorelin does not.
-
Tirzepatide and Birth Control: The 4-Week Rule
Tirzepatide may reduce the absorption of birth control taken by mouth. The current U.S. labels advise non-oral contraception or an added barrier method for four weeks after starting and after every dose increase.
-
Tirzepatide Benefits: What the Trials Show
Tirzepatide benefits are best established for weight reduction and blood-sugar control, with a branded indication for moderate-to-severe sleep apnea in adults with obesity. Heart failure, liver, blood-pressure and lipid findings are promising but narrower.
-
BPC-157 for Tendonitis: What the Evidence Shows
The tendon case for BPC-157 comes from cells and rats, not randomized human trials. Here is what those studies can tell us, what they cannot, and why rehabilitation still matters.
-
Is NAD a Peptide? What NAD+ Actually Is
NAD+ is a dinucleotide coenzyme, not a peptide. Its chemistry, cellular jobs, and evidence are different from the peptide therapies it often appears beside.
-
Liraglutide vs Semaglutide: A Clear Comparison
Both are GLP-1 medicines, but liraglutide is usually injected daily and semaglutide weekly. Head-to-head trials show why the treatment goal and dose matter as much as the molecule.
-
Peptides for Muscle Growth: Evidence and Limits
Prescription GH-axis peptides can change hormone levels and, in selected patients, body composition. Human evidence does not show that they produce hypertrophy or greater strength in healthy trained adults.
-
What Happens When You Stop Taking Tirzepatide?
Appetite suppression fades as tirzepatide clears, and weight regain is common but neither immediate nor inevitable. SURMOUNT-4 shows the difference between stopping and continuing over one year.
-
Peptides for Autoimmune Disease: The Evidence
Thymosin Alpha-1 has meaningful human immune-modulation research, while KPV remains mostly a cell-and-animal finding; neither has clinical evidence that makes it an autoimmune treatment.
Page 6 of 8 · 148 articles